Gastrointestinal Cancer News & Features

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

ASCO Gastrointestinal Cancers Symposium, Jan. 19-21, 2012

January 25, 2012

The American Society of Clinical Oncology's ninth annual Gastrointestinal Cancers Symposium was held from Jan. 19 to 21 in San Francisco; several highlights are detailed.
 

Quality of life after esophagectomy on par with general population for most

January 18, 2012

After surgical treatment of esophageal cancer, quality of life stays the same or gets better for many people, research indicates. Those who show early signs of impaired QoL should be identified and helped.
 

Genetic culprit in pancreatic cancer risk identified

Delicia Honen Yard January 17, 2012

Mutations in the ATM gene may raise a person's hereditary risk for pancreatic cancer, information that could lead to better screening methods for the disease.
 

Study demonstrates mortality disparity among colorectal cancer patients

Delicia Honen Yard January 11, 2012

Concerted efforts to prevent or detect colorectal cancer at earlier stages in black patients could improve the worsening black-white disparities uncovered in a recent analysis.
 

ACS annual report says cancer mortality is decreasing

Delicia Honen Yard January 10, 2012

Cancer incidence rates in men declined by 0.6% per year and remained stable in women and cancer mortality fell by 1.8% per year for men and by 1.6% per year for women between 2004 and 2008.
 

A new era in management of
 gastrointestinal cancers

December 19, 2011

Key studies presented at the 2011 Oncology Congress focus on treatments, prevention, and early diagnosis of GI tract cancers.
 

Risk model helps estimate chances of GI tumor recurrence

Delicia Honen Yard December 16, 2011

Newly developed prognostic maps can assess the likelihood that a gastrointestinal stromal tumor will recur following surgery, reducing inappropriate overtreatment or undertreatment.
 

Gene sequencing can match patients to best cancer trials

Delicia Honen Yard December 15, 2011

Identifying the "mutational landscape" of a person's cancer is a promising method of determining which trials are best-suited to the patient's particular case.
 

Diabetes drug helps prevent growth of breast cancer cells

Delicia Honen Yard December 09, 2011

Metformin, a widely used agent in the treatment of type 2 diabetes, stopped a number of natural and man-made chemicals from stimulating the growth of breast cancer cells.
 

Gastrointestinal Cancer Clinical Trials

Clinical Trial: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Clinical Trial: The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity

Clinical Trial: Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (GIVTE)

Clinical Trial: Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers

Clinical Trial: Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions